Advanced search
Publication Cover
Epigenomics Volume 14, 2022 - Issue 13
Submit an article Journal homepage
1,007
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

A novel methylated cell-free DNA marker panel to monitor treatment response in metastatic prostate cancer

Madonna R Peter1 Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, M5G 1X5, Canada;2 Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, M5S 1A8, CanadaView further author information
,
Misha Bilenky3 Canada’s Michael Smith Genome Science Center, BC Cancer Agency, Vancouver, BC, V5Z 4S6, CanadaView further author information
,
Yuliang Shi4 Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 2C1, CanadaView further author information
,
Jiajie Pu4 Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 2C1, CanadaView further author information
,
Shivani Kamdar1 Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, M5G 1X5, Canada;2 Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, M5S 1A8, CanadaView further author information
,
Aaron R Hansen5 Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, M5G 2C1, CanadaView further author information
,
Neil E Fleshner6 Division of Urology, Department of Surgical Oncology, University Health Network, Toronto, ON, M5G 2C1, CanadaView further author information
,
Srikala S Sridhar5 Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, M5G 2C1, CanadaView further author information
,
Anthony M Joshua5 Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, M5G 2C1, Canada;7 Department of Medical Oncology, Kinghorn Cancer Centre, Darlinghurst, NSW 2010, AustraliaView further author information
,
Martin Hirst3 Canada’s Michael Smith Genome Science Center, BC Cancer Agency, Vancouver, BC, V5Z 4S6, Canada;8 Department of Microbiology & Immunology & Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, CanadaORCID Iconhttps://orcid.org/0000-0001-9136-9054View further author information
ORCID Icon,
Wei Xu4 Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 2C1, CanadaView further author information
&
Bharati Bapat1 Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, M5G 1X5, Canada;2 Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, M5S 1A8, CanadaCorrespondence[email protected]
View further author information
 show all
Pages 811-822 | Received 27 Mar 2022, Accepted 15 Jun 2022, Published online: 12 Jul 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.